![Silvano Spinelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Silvano Spinelli
Fondatore presso
BiovelocITA Srl
Profilo
Silvano Spinelli was the founder of Novuspharma SpA, founded in 1999, where the title held was Chief Executive Officer from 2010 to 2011.
Dr. Spinelli was the founder of EOS SpA, founded in 2006, where the title held was Chief Executive Officer from 2006 to 2012.
Dr. Spinelli is the founder of Enthera Srl, founded in 2016, holding the title of Chairman.
Dr. Spinelli is the founder of BiovelocITA Srl, founded in 2015, holding the title of Chairman since 2015.
Current jobs include Chairman at Alia Therapeutics Srl, Chairman at Nephris Srl, and Venture Partner at Sofinnova Partners SAS since 2018.
Former job includes Managing Director at CTI BioPharma Corp.
Education includes an undergraduate degree from the University of Pisa, conferred in 1976.
Posizioni attive di Silvano Spinelli
| Società | Posizione | Inizio |
|---|---|---|
BiovelocITA Srl
 BiovelocITA Srl Investment ManagersFinance Biovelocita invests in startups located in Italy. The firm focuses on the biotech sector. It provide financing for early stage capital requirements. | Fondatore | 01/01/2015 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 12/03/2018 |
Nephris Srl
 Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Presidente | - |
Alia Therapeutics Srl
 Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Presidente | - |
Enthera Srl
 Enthera Srl BiotechnologyHealth Technology Operates as a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders | Fondatore | 01/01/2016 |
Precedenti posizioni note di Silvano Spinelli
| Società | Posizione | Fine |
|---|---|---|
Novuspharma SpA
 Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Fondatore | 27/07/2011 |
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | 19/08/2005 |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Amministratore Delegato | - |
Formazione di Silvano Spinelli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Novuspharma SpA
Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Health Technology |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
University of Pisa
 University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BiovelocITA Srl
BiovelocITA Srl Investment ManagersFinance Biovelocita invests in startups located in Italy. The firm focuses on the biotech sector. It provide financing for early stage capital requirements. | Finance |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Operates as a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders | Health Technology |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Health Technology |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Commercial Services |
